The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center

被引:3
|
作者
Bian, Dongliang [1 ]
Xiong, Yicheng [1 ]
Jin, Kaiqi [1 ]
Zhu, Yuming [1 ]
Yu, Huansha [2 ]
Dai, Jie [1 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Anim Expt Ctr, Shanghai, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Lung adenocarcinoma stage IA; wedge resection; recurrence; SECTION COMPUTED-TOMOGRAPHY; LIMITED RESECTION; SUBLOBAR RESECTION; SURVIVAL OUTCOMES; CANCER; LOBECTOMY; IMPACT; CLASSIFICATION;
D O I
10.21037/jtd-22-1010
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The effectiveness of segmentectomy for stage IA lung adenocarcinoma (IA-LUAD) has been well-documented. However, the efficacy and safety of wedge resection for peripheral IA-LUAD remains controversial. This study evaluated the feasibility of wedge resection in patients with peripheral IA-LUAD. Methods: Patients with peripheral IA- LUAD who underwent wedge resection by video- assisted thoracoscopic surgery (VATS) at Shanghai Pulmonary Hospital were reviewed. Cox proportional hazards modeling was performed to identify predictors of recurrence. Receiver operating characteristic (ROC) curve analysis was used to calculate the optimal cutoffs of identified predictors. Results: A total of 186 patients (female/male, 115/ 71; mean age, 59.9 years) were included. Mean maximum dimension of consolidation component (MCD) was 5.6 mm, consolidation-to-tumor ratio (CTR) was 37%, and mean computed tomography value of tumor (CTVt) was -285.4 HU. With a median follow-up of 67 months (interquartile range, 52-72 months), the 5-year recurrence rate was 4.84%. Ten patients occurred recurrence postoperatively. No recurrence was observed adjacent to the surgical margin. Increasing MCD, CTR, and CTVt were associated with a higher risk of recurrence, with corresponding hazard ratios (HRs) of 1.212 [95% confidence interval (CI): 1.120-1.311], 1.054 (95% CI: 1.018-1.092), and 1.012 (95% CI: 1.004-1.019) with optimal cutoffs for predicting recurrence of 10 mm, 60%, and -220 HU, respectively. When a tumor had characteristics under these respective cutoffs, no recurrence was observed. Conclusions: Wedge resection can be considered to be a safe and efficacious management strategy for patients with peripheral IA-LUAD, especially for MCD less than 10 mm, CTR less than 60% and CTVt less than -220 HU.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [31] A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer
    Handa, Yoshinori
    Tsutani, Yasuhiro
    Mimae, Takahiro
    Miyata, Yoshihiro
    Shimada, Yoshihisa
    Ito, Hiroyuki
    Nakayama, Haruhiko
    Ikeda, Norihiko
    Okada, Morihito
    CLINICAL LUNG CANCER, 2022, 23 (05) : 393 - 401
  • [32] A Multi-Center Real-World Study of Clinicopathologic Characteristics and Efficacy of the Malignant Mesothelioma in Chinese Population
    Sun, Chenrui
    Yang, Xue
    Chen, Lan
    Bie, Zhixin
    Kang, Runting
    Ai, Bin
    Ma, Junling
    Zheng, Zitong
    Liu, Haolan
    Liu, Juanjuan
    Zhong, Jia
    Yu, Jiangyong
    THORACIC CANCER, 2025, 16 (03)
  • [33] Gene mutation in diabetic patients with lung adenocarcinoma: a real-world retrospective cohort study
    Yang, Lei
    Hong, Yang
    Zeng, Tingting
    Yue, Hongmei
    Jiang, Depeng
    FRONTIERS IN MEDICINE, 2025, 12
  • [34] Surgical resection versus radiotherapy for clinical stage IA lung cancer <1 cm in size: A population-based study
    Huang, Weijia
    Deng, Han-Yu
    Wu, Xiao-Na
    Xu, Kai
    Li, Peiwei
    Lin, Ming-Ying
    Yuan, Chi
    Zhou, Qinghua
    ASIAN JOURNAL OF SURGERY, 2023, 46 (01) : 385 - 393
  • [35] Development and validation of a CT-based nomogram to predict spread through air space (STAS) in peripheral stage IA lung adenocarcinoma
    Chen, Yaxi
    Jiang, Changsi
    Kang, Wenyan
    Gong, Jingshan
    Luo, Dehong
    You, Shuyuan
    Cheng, Zhiqiang
    Luo, Yan
    Wu, Kongyang
    JAPANESE JOURNAL OF RADIOLOGY, 2022, 40 (06) : 586 - 594
  • [36] Exploring the impact of variable power outputs on the efficacy and safety during microwave ablation for lung carcinoma: a real-world study
    Cui, Song-Ping
    Zhao, Qing
    Wang, Jing
    Ji, Ying
    Miao, Jin-Bai
    Fu, Yi-Li
    Hu, Bin
    Chen, Shuo
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5031 - 5041
  • [37] Conditional survival rate estimates of lobectomy, segmentectomy and wedge resection for stage IA1 non-small cell lung cancer: A population-based study
    Fan, Xiaoxi
    Liang, Yicheng
    Bai, Yunpeng
    Yang, Chunlu
    Xu, Shun
    ONCOLOGY LETTERS, 2020, 20 (02) : 1607 - 1618
  • [38] A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study)
    Shimoyama, Ryo
    Tsutani, Yasuhiro
    Wakabayashi, Masashi
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Suzuki, Kenji
    Watanabe, Shun-ichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1209 - 1213
  • [39] Intentional wedge resection versus segmentectomy for ≤2 cm ground-glass-opacity-dominant non-small cell lung cancer: a real-world study using inverse probability of treatment weighting
    Liu, Chengwu
    Yang, Zhenyu
    Li, Yiming
    Guo, Chenglin
    Xia, Liang
    Zhang, Weiheng
    Xiao, Congjia
    Mei, Jiandong
    Liao, Hu
    Zhu, Yunke
    Lin, Feng
    Ma, Lin
    Pu, Qiang
    Liu, Lunxu
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (07) : 4231 - 4239
  • [40] Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study
    Hanbo Pan
    Ningyuan Zou
    Yu Tian
    Yaofeng Shen
    Hang Chen
    Hongda Zhu
    Jiaqi Zhang
    Weiqiu Jin
    Zenan Gu
    Junwei Ning
    Long Jiang
    Jia Huang
    Qingquan Luo
    Annals of Surgical Oncology, 2024, 31 : 1568 - 1580